A. Cseh
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 35
- Oncology 22
- HER2/EGFR in Cancer Research 11
- Colorectal Cancer Treatments and Studies 7
- Peptidase Inhibition and Analysis 5
- Lung Cancer Research Studies 4
- Co-authors
- Flavio Solca (11 shared papers)Petr Kavan (3 shared papers)Maximilian J. Hochmair (6 shared papers)David A. Reardon (3 shared papers)Helmut Prosch (2 shared papers)David Mathieu (1 shared paper)Stephen V. Liu (6 shared papers)Sophia Schwab (2 shared papers)
- Journals
- Annals of Oncology (11 papers)Journal of Thoracic Oncology (9 papers)Frontiers in Oncology (2 papers)OncoTargets and Therapy (2 papers)Future Oncology (2 papers)
- Partner nations
- United StatesAustriaGermany
In The Last Decade
A. Cseh
36 papers receiving 633 citations
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 365
- Oncology 308
- Genetics 120
- Cancer Research 134
- Pathology and Forensic Medicine 43
Countries citing papers authored by A. Cseh
This map shows the geographic impact of A. Cseh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cseh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cseh more than expected).
Fields of papers citing papers by A. Cseh
This network shows the impact of papers produced by A. Cseh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cseh. The network helps show where A. Cseh may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Cseh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 141 | |
| 2 | 2020 | 103 | |
| 3 | 2018 | 89 | |
| 4 | 2018 | 68 | |
| 5 | 2020 | 45 | |
| 6 | 2014 | 23 | |
| 7 | 2020 | 22 | |
| 8 | 2015 | 17 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2017 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2017 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2019 | 4 |
About A. Cseh
A. Cseh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Genetics and Neurology, having authored 39 papers that have together received 639 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), HER2/EGFR in Cancer Research (11 papers), Colorectal Cancer Treatments and Studies (7 papers), Peptidase Inhibition and Analysis (5 papers), Lung Cancer Research Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (365 citations), Oncology (308 citations), Genetics (120 citations), Cancer Research (134 citations) and Pathology and Forensic Medicine (43 citations). A. Cseh has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include Flavio Solca, Petr Kavan, Maximilian J. Hochmair, David A. Reardon, Helmut Prosch, David Mathieu, Stephen V. Liu, Sophia Schwab, M. Duruisseaux and Parneet Cheema. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Frontiers in Oncology, OncoTargets and Therapy and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.